跳至主要内容
临床试验/NCT01668888
NCT01668888已完成不适用

Progranulin and CTRP3 in Metabolic Syndrome

Korea University1 个研究点 分布在 1 个国家目标入组 127 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
127
试验地点
1
主要终点
Serum concentration of progranulin in the subjects with metabolic syndrome

研究概览

简要总结

Inflammation has been known to be a pivotal pathogenic mechanism of obesity-related disorders such as type 2 diabetes, metabolic syndrome and atherosclerosis. Adipose tissue functions as a major endocrine organ by adipokine mediated modulation of a number of signaling cascades in target tissues, that has pro-inflammatory or anti-inflammatory activities. Progranulin and CTRP3 are recently discovered novel adipokines. Therefore, the investigators tried to clarify the clinical meaning of these two adipokines in the subjects with or without metabolic syndrome

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 20<age<80
  • apparently healthy subjects

排除标准

  • a history of CVD
  • stage 2 hypertension
  • malignancy
  • severe renal or hepatic disease

结局指标

主要结局

Serum concentration of progranulin in the subjects with metabolic syndrome

时间窗: 12week

Serum concentration of CTRP3 in the subjects with metabolic syndrome

时间窗: 12week

次要结局

  • The relationship of serum progranulin levels with cardiovascular risk factors(12 week)
  • The relationship of serum CTRP3 levels with cardiovascular risk factors(12 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

K. M. Choi

Professor

Korea University

研究点 (1)

Loading locations...

相似试验